Purinostat, CAS [[1929583-17-4]] Preis auf Anfrage

Artikelnummer: TGM-T204269
Artikelname: Purinostat, CAS [[1929583-17-4]] Preis auf Anfrage
Artikelnummer: TGM-T204269
Hersteller Artikelnummer: T204269
Alternativnummer: TGM-T204269-10MG,TGM-T204269-50MG
Hersteller: TargetMol
Kategorie: Biochemikalien
Purinostat is a selective inhibitor of HDACI/IIb with potential anti-leukemic properties. Its mesylate form, Purinostat mesylate, is effective at inhibiting the survival of Ph+ leukemic cells and CD34+ leukemic cells derived from CML patients. Purinostat mesylate targets HDACI/IIb, impacting several crucial factors for leukemia stem cell (LSC) survival, such as c-Myc, beta-Catenin, E2f, Ezh2, Alox5, and mTOR. Additionally, Purinostat mesylate enhances glutamate metabolism in LSCs by increasing GLS1.
Molekulargewicht: 490.518
CAS Nummer: [1929583-17-4]
Formel: C23H26N10O3
Target-Kategorie: HDAC
T204269